Search

everythinglearnresearchcommunity

for

Search:↓

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Raman spectroscopy is promising for measuring and enhancing drug delivery in alopecia treatments.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Ferret hair growth starts between 0 and 4 days after melatonin treatment, with cell growth peaking in the hair germ and declining as the hair matures.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Injecting steroids like Triamcinolone Acetonide for skin treatments can cause Cushing's Syndrome.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Some nonsurgical hair loss treatments are effective, especially if started early.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Lugol's solution can cause thyroid problems if used long-term for non-approved reasons.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

PRP and PRF show promise for hair growth but need more research for consistent and safe use.

Pharmacists play a crucial role in improving treatment outcomes and staying updated on various health conditions.

A portable imaging system shows promise for diagnosing skin diseases and checking laser treatment effects.

Latisse (bimatoprost 0.03%) is widely used in dermatology but the document doesn't give detailed evidence or numbers.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

CRH causes hair loss by reducing autophagy and increasing cell death in hair cells.

CRH causes hair loss by reducing cell survival in hair follicles.

Finasteride and minoxidil are approved treatments for hair loss, and hair transplants can be effective but require careful patient selection.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

A new method found unlisted drugs in two popular hair serums, posing a health risk.

64 drugs can cause hair loss, needing better monitoring and updated labels.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

Children with alopecia areata need supportive care and off-label treatments due to a lack of approved options.